Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

We recently compiled a list of the 10 Best Non-Tech Stocks to Buy Now for Long Term. In this article, we are going to take a ...

Eli Lilly’s stock price fell to $872.91. Shareholders have lost 8.3% of their capital, which is disappointing considering the ...

Commenting on LLY’s Q4 results, Seeking Alpha analyst BioCGT Investor noted that with the company’s 2025 guidance implying 31% revenue growth and nearly 80% non-GAAP EPS growth, the stock ...

Eli Lilly (NYSE: LLY) stock inched 2.5% higher through 9:50 a.m. ET Thursday after beating on the top and bottom lines in this morning's Q4 earnings report. Heading into the report, analysts ...

Trading volume stands at 4,662,591, with LLY's price up by 3.71%, positioned at $873.4. RSI indicators show the stock to be may be approaching overbought. Earnings announcement expected in 0 days.

Is Eli Lilly a Buy Right Now? Turning to Wall Street, analysts have a Strong Buy consensus rating on LLY stock based on 17 Buys and one Hold assigned in the past three months, as indicated by the ...

On February 5, 2024, Eli Lilly and Company (NYSE:LLY) stock closed at $842.18 per share, with a market capitalization of $757.386 billion. Alger Spectra Fund stated the following regarding Eli Lilly ...

So far this year, LLY is up 7% and primed to continue its uptrend on the back of key business unit catalysts. Over the past 3 years, the stock has been up almost 250% while generating $1.5 per sha ...

ELI LILLY AND CO (LLY) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 88% based on the firm’s underlying fundamentals and the stock’s ...